{"id":"https://openalex.org/W4415900311","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","title":"576 Third-party tumor-associated antigen-specific T cells demonstrate safety in patients with high-risk pediatric solid tumors: preliminary results from a phase I clinical trial","display_name":"576 Third-party tumor-associated antigen-specific T cells demonstrate safety in patients with high-risk pediatric solid tumors: preliminary results from a phase I clinical trial","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4415900311","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0576"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0576","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A655.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/13/Suppl_2/A655.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085372074","display_name":"Amy B Hont","orcid":"https://orcid.org/0000-0002-3663-3956","observed_orcids":["https://orcid.org/0000-0002-3663-3956"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy B Hont","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Samantha Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Murphy","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033997937","display_name":"Carolina Colli Cruz","orcid":"https://orcid.org/0000-0001-7065-3769","observed_orcids":["https://orcid.org/0000-0001-7065-3769"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Conrad R Cruz","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066139971","display_name":"Patrick J. Hanley","orcid":"https://orcid.org/0000-0002-0102-7892","observed_orcids":["https://orcid.org/0000-0002-0102-7892"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J Hanley","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083465874","display_name":"Chase D. McCann","orcid":"https://orcid.org/0000-0002-9178-2110","observed_orcids":["https://orcid.org/0000-0002-9178-2110"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chase D McCann","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110399552","display_name":"Haili Lang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haili Lang","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042431577","display_name":"Anushree A. Datar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anushree Datar","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082284305","display_name":"Syeda Fatima","orcid":"https://orcid.org/0000-0003-1425-7707","observed_orcids":["https://orcid.org/0000-0003-1425-7707"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Syeda Z Fatima","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039373531","display_name":"Rachel DiCioccio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel DiCioccio","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057892885","display_name":"Fahmida Hoq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fahmida Hoq","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006134549","display_name":"Catherine M. Bollard","orcid":"https://orcid.org/0000-0001-5140-9090","observed_orcids":["https://orcid.org/0000-0001-5140-9090"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine M Bollard","raw_affiliation_strings":["Children\u2019s National Hospital, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s National Hospital, Washington, DC, USA","institution_ids":["https://openalex.org/I1336742384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1336742384"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A655","last_page":"A655"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.27000001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.7289999723434448},{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":1.0},{"id":"https://openalex.org/keywords/survivin","display_name":"survivin","score":1.0},{"id":"https://openalex.org/keywords/off-the-shelf-t-cell-therapy","display_name":"off-the-shelf T cell therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.6869999766349792},{"id":"https://openalex.org/keywords/stable-disease","display_name":"stable disease","score":0.5759999752044678},{"id":"https://openalex.org/keywords/antigen-spreading","display_name":"antigen spreading","score":0.7710000276565552},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.7429999709129333},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.574999988079071},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.3269999921321869},{"id":"https://openalex.org/keywords/hla-matching","display_name":"HLA matching","score":0.6079999804496765},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.6880000233650208},{"id":"https://openalex.org/keywords/t-cell-immunotherapy","display_name":"T cell therapy","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8115000128746033},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5525000095367432},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5030999779701233},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3418000042438507},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3319999873638153},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.29840001463890076},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.26969999074935913},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.26910001039505005},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.23970000445842743},{"id":"https://openalex.org/C2777371436","wikidata":"https://www.wikidata.org/wiki/Q3237071","display_name":"Leukapheresis","level":4,"score":0.23190000653266907}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2025-sitc2025.0576","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A655.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2025-sitc2025.0576","doi":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0576","pdf_url":"https://jitc.bmj.com/content/13/Suppl_2/A655.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320338488","display_name":"DOD Peer Reviewed Cancer Research Program","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415900311.pdf","grobid_xml":"https://content.openalex.org/works/W4415900311.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2892200488","https://openalex.org/W2964620721","https://openalex.org/W4388047652","https://openalex.org/W4308375615","https://openalex.org/W3103766090","https://openalex.org/W4281700672","https://openalex.org/W2910692741","https://openalex.org/W2983918436","https://openalex.org/W4414531192","https://openalex.org/W7166690226"],"abstract_inverted_index":{"Background":[0],"T":[1,20],"cell":[2,21],"therapies":[3],"offer":[4],"a":[5,101,121,143,193,339,360,370,387,457],"promising,":[6],"targeted":[7],"approach":[8,362],"for":[9,120,351,369,393],"patients":[10,34,91,111,191,209,233,293,311,319,352,455],"with":[11,35,38,92,112,138,176,214,220,229,294,305,320,379,448,456],"relapsed/refractory":[12],"(r/r)":[13],"solid":[14,94,115,216,297],"tumors.":[15,116,462],"Patient-derived":[16],"multi":[17],"tumor-associated":[18],"antigen-specific":[19,139,185],"(TAA-T)":[22],"products":[23,50,77,97,169,201,285],"targeting":[24],"WT1,":[25],"PRAME,":[26],"and":[27,58,81,147,158,165,183,228,239,268,270],"survivin":[28],"have":[29,62],"been":[30],"safely":[31,447],"administered":[32,99,202],"to":[33,87,110,162,207,260],"r/r":[36,93,113,215,296],"disease":[37,39,128,236,316,323,325,380,452],"stabilization":[40,237,453],"but":[41],"without":[42],"objective":[43,246],"clinical":[44,106,247],"responses.":[45],"The":[46,422],"autologous":[47],"patient-derived":[48,88],"TAA-T":[49,76,89,96,168,198,200,284,445],"expressed":[51],"multiple":[52],"markers":[53],"of":[54,127,188,273,288,308,315,334,359,390,406,450,459],"exhaustion":[55],"(PD1,":[56],"CTLA4,":[57],"CD39),":[59],"which":[60],"may":[61,364],"limited":[63],"anti-tumor":[64,84,166,373],"potency":[65],"in":[66,90,124,196,275,290,292,331,347,382,454],"vivo.":[67],"We":[68],"hypothesized":[69],"that":[70,344,363],"treatment":[71],"using":[72,152,396],"healthy":[73,174],"donor-derived":[74,283],"off-the-shelf":[75],"will":[78],"be":[79],"safe":[80],"elicit":[82],"enhanced":[83],"activity":[85,140],"compared":[86],"tumors.Methods":[95],"were":[98,118,150,170,218,244],"on":[100,134],"phase":[102],"I":[103],"dose":[104,123,205,222,301],"escalation":[105],"trial":[107],"(":[108,249],"NCT05238792)":[109],"pediatric":[114],"Patients":[117],"eligible":[119],"second":[122],"the":[125,197,332,356,366,404,427],"absence":[126,333],"progression.":[129],"Product":[130],"selection":[131],"was":[132,327,345,377,401,424],"based":[133],"best":[135],"overall":[136],"match":[137,194],"mediated":[141],"through":[142],"shared":[144],"allele.":[145],"Clinical":[146],"immunobiological":[148],"studies":[149,254,337],"performed":[151],"radiologic":[153],"studies,":[154],"flow":[155],"cytometric,":[156],"multiplex,":[157],"IFNy":[159],"ELISpot":[160],"assays":[161],"assess":[163],"immunologic":[164],"responses.Results":[167],"generated":[171],"from":[172],"3":[173],"donors":[175],"diverse":[177],"HLA":[178],"types,":[179],"demonstrating":[180],"polyfunctional":[181],"phenotype":[182],"HLA-restricted":[184],"activity.":[186],"Six":[187],"7":[189],"screened":[190],"had":[192],"identified":[195,338],"bank.":[199],"over":[203,299],"2":[204,300],"levels":[206,272],"6":[208],"(age":[210],"range":[211],"18-66":[212],"years)":[213],"tumors":[217,298],"well-tolerated":[219],"no":[221,245],"limiting":[223],"toxicities,":[224],"both":[225,318],"alone":[226],"(n=3)":[227],"lymphodepletion":[230],"(n=3).":[231],"Two":[232,307],"achieved":[234],"prolonged":[235,451],"[(408":[238],"416":[240],"(ongoing)":[241],"days];":[242],"there":[243],"responses":[248],"figure":[250],"1).":[251],"Preliminary":[252],"correlative":[253],"demonstrate":[255,286],"an":[256,276],"antigen":[257,341],"spreading":[258,342],"response":[259,343],"non-targeted":[261],"antigens":[262],"MAGE":[263,265],"A3,":[264],"A4,":[266],"SSX-2,":[267],"SOX-2":[269],"elevated":[271],"IL-8":[274,376],"otherwise":[277],"quiescent":[278],"circulating":[279],"cytokine":[280],"milieu.Conclusions":[281],"Healthy":[282],"evidence":[287,449],"safety":[289],"vivo":[291],"high-risk,":[295],"levels,":[302],"including":[303],"conditioning":[304],"lymphodepletion.":[306],"six":[309],"(33%)":[310],"experienced":[312],"long":[313],"periods":[314],"stabilization,":[317],"minimal":[321],"residual":[322],"though":[324],"status":[326],"not":[328],"fully":[329],"defined":[330],"biopsy.":[335],"Correlative":[336],"small":[340],"muted":[346],"early":[348],"time":[349],"points":[350],"receiving":[353],"lymphodepletion,":[354],"suggesting":[355],"potential":[357,388],"benefit":[358],"combinatorial":[361],"augment":[365],"immune":[367],"milieu":[368],"more":[371],"potent":[372],"response.":[374],"Elevated":[375],"correlated":[378],"progression":[381],"this":[383],"patient":[384],"population,":[385],"representing":[386],"mechanism":[389],"therapeutic":[391],"enhancement":[392],"future":[394],"study":[395,423],"engineering":[397],"strategies.Acknowledgements":[398],"This":[399],"work":[400],"supported":[402],"by":[403,426],"Department":[405],"Defense":[407],"Peer":[408],"Reviewed":[409],"Cancer":[410],"Research":[411],"Program":[412],"Career":[413],"Development":[414],"Award":[415],"(W81XWH2110259).Trial":[416],"Registration":[417],"Clinicaltrials.gov":[418],"identifier":[419],"NCT05238792Ethics":[420],"Approval":[421],"approved":[425],"Children\u2019s":[428],"National":[429],"Hospital\u2019s":[430],"Institutional":[431],"Review":[432],"Board,":[433],"approval":[434],"number":[435],"Pro00016539,":[436],"IND":[437],"27716.Abstract":[438],"576":[439],"Figure":[440],"1Patients":[441],"received":[442],"partially":[443],"HLA-matched":[444],"infusions":[446],"history":[458],"rapidly":[460],"progressive":[461],"OS:":[463],"osteosarcoma;":[464],"WT:":[465],"Wilms":[466],"tumor;":[467],"NB:":[468],"neuroblastoma;":[469],"Data":[470],"censored":[471],"June":[472],"30,":[473],"2025":[474]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-05T00:00:00"}